|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.25 USD | +0.64% |
|
+3.66% | +13.38% |
| 01:16pm | Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction | RE |
| 06-10 | TD Cowen Adjusts Price Target on DexCom to $95 From $75, Maintains Buy Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 28,852 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 11.46% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 28,482 | 27,604 | 26,498 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 8.68% | -3.08% | -4.01% |
| P/E Ratio | 346x | 138x | 95.5x | 54.8x | 31.8x | 30.5x | 25.6x | 21.3x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.1x | 10.8x | 7.79x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.3x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.52x | 4.95x | 4.42x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.45x | 4.74x | 4.06x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.4x | 14.5x | 11.9x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 23.5x | 19.2x | 15.4x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 28.7x | 22.2x | 17.5x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.49% | 4.5% | 5.72% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,525 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,637 | 1,909 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,437 | 1,721 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -369.5 | -1,248 | -2,354 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 74.77 | 74.77 | 74.77 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 2/10/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.55x | 5.45x | 17.4x | -.--% | 28.85B | |
| 22.43x | 3.32x | 12.49x | 2.85% | 155B | |
| 20.17x | 3.48x | 12.52x | 3.56% | 103B | |
| 14.82x | 0.18x | 11.11x | 0.84% | 54.72B | |
| 35.03x | 8.65x | 23.28x | 1.1% | 53.65B | |
| 36.82x | 2.95x | 10.13x | 2.61% | 40.72B | |
| 34.98x | 1.3x | 11.43x | 0.22% | 30.9B | |
| 39.3x | 6.8x | 24.52x | 0.27% | 23.38B | |
| 24.9x | 3.17x | 12.94x | 1.3% | 21.22B | |
| 23.08x | 3.33x | 11.97x | 1.27% | 20.31B | |
| Average | 28.21x | 3.86x | 14.78x | 1.4% | 53.21B | |
| Weighted average by Cap. | 25.61x | 3.68x | 13.99x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
